These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
338 related items for PubMed ID: 18821619
1. Magnetic resonance imaging and spectroscopy for monitoring liver steatosis. Cowin GJ, Jonsson JR, Bauer JD, Ash S, Ali A, Osland EJ, Purdie DM, Clouston AD, Powell EE, Galloway GJ. J Magn Reson Imaging; 2008 Oct; 28(4):937-45. PubMed ID: 18821619 [Abstract] [Full Text] [Related]
2. Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered. McPherson S, Jonsson JR, Cowin GJ, O'Rourke P, Clouston AD, Volp A, Horsfall L, Jothimani D, Fawcett J, Galloway GJ, Benson M, Powell EE. J Hepatol; 2009 Aug; 51(2):389-97. PubMed ID: 19505740 [Abstract] [Full Text] [Related]
3. Hepatic fat quantification using chemical shift MR imaging and MR spectroscopy in the presence of hepatic iron deposition: validation in phantoms and in patients with chronic liver disease. Lee SS, Lee Y, Kim N, Kim SW, Byun JH, Park SH, Lee MG, Ha HK. J Magn Reson Imaging; 2011 Jun; 33(6):1390-8. PubMed ID: 21591008 [Abstract] [Full Text] [Related]
5. Measurement of liver fat by magnetic resonance imaging: Relationships with body fat distribution, insulin sensitivity and plasma lipids in healthy men. Chan DC, Watts GF, Ng TW, Hua J, Song S, Barrett PH. Diabetes Obes Metab; 2006 Nov; 8(6):698-702. PubMed ID: 17026495 [Abstract] [Full Text] [Related]
6. [Measurement of intrahepatic triglyceride stores by 1H magnetic resonance spectroscopy: study with rat models and in patients]. Liu M, Gao X, Rao SX, Wu L, Zeng MS. Zhonghua Yi Xue Za Zhi; 2008 Feb 26; 88(8):531-3. PubMed ID: 18649768 [Abstract] [Full Text] [Related]
9. Liver steatosis quantification using magnetic resonance imaging: a prospective comparative study with liver biopsy. Mennesson N, Dumortier J, Hervieu V, Milot L, Guillaud O, Scoazec JY, Pilleul F. J Comput Assist Tomogr; 2009 Feb 26; 33(5):672-7. PubMed ID: 19820490 [Abstract] [Full Text] [Related]
10. Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in/opposed-phase and spectral-spatial excitation techniques. Schwenzer NF, Machann J, Martirosian P, Stefan N, Schraml C, Fritsche A, Claussen CD, Schick F. Invest Radiol; 2008 May 26; 43(5):330-7. PubMed ID: 18424954 [Abstract] [Full Text] [Related]
11. Noninvasive quantification of hepatic steatosis in rats using 3.0 T 1H-magnetic resonance spectroscopy. Marsman HA, van Werven JR, Nederveen AJ, Ten Kate FJ, Heger M, Stoker J, van Gulik TM. J Magn Reson Imaging; 2010 Jul 26; 32(1):148-54. PubMed ID: 20578022 [Abstract] [Full Text] [Related]
12. Non-invasive quantification of hepatic fat fraction by fast 1.0, 1.5 and 3.0 T MR imaging. Schuchmann S, Weigel C, Albrecht L, Kirsch M, Lemke A, Lorenz G, Warzok R, Hosten N. Eur J Radiol; 2007 Jun 26; 62(3):416-22. PubMed ID: 17267159 [Abstract] [Full Text] [Related]
14. Dual-echo, chemical shift gradient-echo magnetic resonance imaging to quantify hepatic steatosis: Implications for living liver donation. Rinella ME, McCarthy R, Thakrar K, Finn JP, Rao SM, Koffron AJ, Abecassis M, Blei AT. Liver Transpl; 2003 Aug 26; 9(8):851-6. PubMed ID: 12884199 [Abstract] [Full Text] [Related]
15. Quantification of hepatic steatosis: a comparison of the accuracy among multiple magnetic resonance techniques. Wu CH, Ho MC, Jeng YM, Hsu CY, Liang PC, Hu RH, Lai HS, Shih TT. J Gastroenterol Hepatol; 2014 Apr 26; 29(4):807-13. PubMed ID: 24224538 [Abstract] [Full Text] [Related]
16. Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Thomas EL, Hamilton G, Patel N, O'Dwyer R, Doré CJ, Goldin RD, Bell JD, Taylor-Robinson SD. Gut; 2005 Jan 26; 54(1):122-7. PubMed ID: 15591516 [Abstract] [Full Text] [Related]
17. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S, Hobbs HH, Dobbins RL. Am J Physiol Endocrinol Metab; 2005 Feb 26; 288(2):E462-8. PubMed ID: 15339742 [Abstract] [Full Text] [Related]